1. Home
  2. WVE vs HYLN Comparison

WVE vs HYLN Comparison

Compare WVE & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.69

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

SELL

Current Price

$3.41

Market Cap

587.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
WVE
HYLN
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
673.9M
587.6M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
WVE
HYLN
Price
$3.69
$3.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
4
Target Price
★ $17.11
$7.75
AVG Volume (30 Days)
★ 3.0M
1.4M
Earning Date
10-27-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,704,000.00
$3,475,000.00
Revenue This Year
$46.45
$334.53
Revenue Next Year
N/A
$139.40
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 149.43
130.28
52 Week Low
$3.04
$1.56
52 Week High
$21.73
$8.49

Technical Indicators

Market Signals
Indicator
WVE
HYLN
Relative Strength Index (RSI) 51.82 46.41
Support Level $3.04 $3.16
Resistance Level $4.07 $4.62
Average True Range (ATR) 0.20 0.19
MACD 0.10 0.00
Stochastic Oscillator 76.83 51.91

Price Performance

Historical Comparison
WVE
HYLN

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.

Share on Social Networks: